about
Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiencySpatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapyActive versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?Learning therapeutic lessons from metastasis suppressor proteins.In vitro characterization and micromechanics of tumor cell chemotactic protrusion, locomotion, and extravasation.Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells.Suppression of colorectal cancer liver metastasis by apolipoprotein(a) kringle V in a nude mouse model through the induction of apoptosis in tumor-associated endothelial cells.Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells.Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors.Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brainTherapeutic targets for antimetastatic therapy.Pathobiology of brain metastases.Modulating the vascular behavior of metastatic breast cancer cells by curcumin treatmentTumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.Osteopontin: an emerging therapeutic target for anticancer therapy.Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9The tumor microenvironment: the making of a paradigm.Anti-Metastatic and Anti-Angiogenic Activities of Core-Shell SiO2@LDH Loaded with Etoposide in Non-Small Cell Lung Cancer.Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation.Neutrophils influence melanoma adhesion and migration under flow conditions.Rethinking the metastatic cascade as a therapeutic target.Cancer stem cells, tumor dormancy, and metastasis.Interrogating Patient-level Genomics and Mouse Phenomics towards Understanding Cytokines in Colorectal Cancer MetastasisSynthesis and evaluation of trehalose-based compounds as novel inhibitors of cancer cell migration and invasion.Antimetastatic effects of licochalcone A on oral cancer via regulating metastasis-associated proteases.A novel protein from Eupolyphaga sinensis inhibits adhesion, migration, and invasion of human lung cancer A549 cells.The minimum element of a synthetic peptide required to block prostate tumor cell migration.Hydrodynamic shear rate regulates melanoma-leukocyte aggregation, melanoma adhesion to the endothelium, and subsequent extravasationDiscovery of a Series of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion.Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model.The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis.Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8.
P2860
Q24800925-CF3EC9AB-BB96-4502-9015-A8874B8D5555Q28544732-70BD6286-7115-4442-8805-DF4F28DFACEEQ29308099-AADEF95A-38DC-46DD-B258-CB852FA4C649Q30435922-2DDE50EC-83EA-46FE-8B38-0B53E0738102Q30437679-2480883F-43F5-4881-ADB9-136705517F28Q30465825-095B000A-E1AA-4B25-A39F-8C22B9392B6EQ31156540-3F1F4567-9117-4375-BCEE-9BA60A12D096Q33770947-37E4D956-E7AD-4071-B381-7031315BC794Q33882549-6D7BC16A-BEB2-4A01-89EC-D1BA0EFC4D3CQ34414905-2E4BA51F-2316-48E2-90BB-8C32DEDABB4DQ35609713-DACB37EC-9ACA-4AE7-8D43-680862982CB9Q35656166-CDABDD76-F627-48AF-B0D5-01115FD2562CQ35976350-C2DDCC66-1C9C-4FAB-BC83-88DF7F70AADBQ36056424-1E9FA4DC-6EDB-497D-98DE-F3AF83057D23Q36401153-029C29CD-03D6-42CF-B6FF-5674EFDC54DCQ36616513-22846B5B-8DEB-459E-A996-68FDDB2FB36AQ36675504-EF8D4A8E-9BC2-4016-8FCA-AD8F0B411D4EQ36741062-220D767D-E574-4546-8478-B206CF69AEDCQ37373366-8C922DDB-0907-43DD-877E-FCB2E41C0069Q37404656-9DA3CF79-B3F9-4E56-8CE6-12D3557EF9DBQ37421601-7A719C2B-F514-459E-9679-2510562D20F0Q37424807-7D8092E2-EE1A-4B5D-8C17-1FB6CB9CBDEFQ37866635-1CA6700C-4BD1-459C-9B47-9B3F035A53BBQ38056500-C51957E1-0957-4355-8DBF-3E250BB80901Q38621147-6747EA37-2DEE-4763-BC6D-6FFCB7F670FBQ38889532-E8A673A9-891C-4F2D-B175-97531924826FQ38999386-8888DE24-24C7-411D-B2B1-EDF206CF6DD1Q39125266-0923D3DB-099E-43AF-89CE-59504F854ED7Q40208879-F079D4F8-A648-4C01-82EA-83ABB975C8E3Q42082506-28FDBD06-B48B-42BE-BD2F-1C636AFBEF3CQ43225266-274A9620-1CCB-44A3-AE17-953FFD9DB65EQ44150695-A0EE3876-3D36-45A8-9B0B-6678068E5BA2Q53275341-7C6B018E-3E45-456A-A4D8-4C6F8C3A5850Q55162514-6B8CEB32-897C-42E8-9181-F2DCB2E9ADE4
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Clinical targets for anti-metastasis therapy.
@ast
Clinical targets for anti-metastasis therapy.
@en
type
label
Clinical targets for anti-metastasis therapy.
@ast
Clinical targets for anti-metastasis therapy.
@en
prefLabel
Clinical targets for anti-metastasis therapy.
@ast
Clinical targets for anti-metastasis therapy.
@en
P2093
P1476
Clinical targets for anti-metastasis therapy.
@en
P2093
Chambers AF
MacDonald IC
Schmidt EE
P304
P356
10.1016/S0065-230X(00)79003-8
P577
2000-01-01T00:00:00Z